Cryo-Cell Intl Inc (CCEL) Stock Price, Quote & News

Latest News on CCEL

Oct 30, 2024, 8:45 AM EDT - 2 months ago

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

Oct 15, 2024, 5:20 PM EDT - 3 months ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

Jul 15, 2024, 4:30 PM EDT - 6 months ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

Apr 15, 2024, 5:00 PM EDT - 9 months ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

Mar 25, 2024, 9:00 AM EDT - 10 months ago

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

Feb 28, 2024, 5:00 PM EST - 11 months ago

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

Oct 12, 2023, 4:45 PM EDT - 1 year ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

Jul 14, 2023, 4:15 PM EDT - 1 year ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

Apr 21, 2023, 4:15 PM EDT - 1 year ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

Feb 28, 2023, 5:15 PM EST - 2 years ago

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022

Oct 14, 2022, 4:15 PM EDT - 2 years ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

Aug 22, 2022, 6:00 PM EDT - 2 years ago

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

Aug 17, 2022, 5:00 PM EDT - 2 years ago

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

Jul 11, 2022, 4:30 PM EDT - 2 years ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

Apr 13, 2022, 4:30 PM EDT - 3 years ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

Mar 16, 2022, 4:30 PM EDT - 3 years ago

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

Mar 9, 2022, 4:15 PM EST - 3 years ago

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

Feb 22, 2022, 4:30 PM EST - 3 years ago

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

Feb 11, 2022, 5:16 PM EST - 3 years ago

Cryo-Cell International: A Stable Business Paired With An Upcoming Catalyst

Oct 27, 2021, 4:15 PM EDT - 3 years ago

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

Oct 15, 2021, 4:36 PM EDT - 3 years ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

Sep 20, 2021, 6:05 PM EDT - 3 years ago

Cryo-Cell International Announces Changes To Its Board of Directors

Aug 30, 2021, 9:00 AM EDT - 3 years ago

Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Aug 20, 2021, 9:04 AM EDT - 3 years ago

Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies

Aug 11, 2021, 12:03 PM EDT - 3 years ago

Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021

Aug 11, 2021, 9:00 AM EDT - 3 years ago

Cryo-Cell International to Present at the Q3 Virtual Investor Summit

Jul 15, 2021, 7:27 PM EDT - 3 years ago

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results

Jun 25, 2021, 2:05 PM EDT - 3 years ago

Cryo-Cell International: Overlooked Duke Contract Signals Business Inflection

May 10, 2021, 9:00 AM EDT - 4 years ago

Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials

Apr 14, 2021, 6:14 PM EDT - 4 years ago

Market Cap	59.66M
Revenue (ttm)	31.34M
Net Income (ttm)	-9.52M
EPS (ttm)	N/A
PE Ratio	13.04
Forward PE	N/A
Profit Margin	-30.38%
Debt to Equity Ratio	-1.10

Volume	9,700
Avg Vol	17,490
Day's Range	N/A - N/A
Shares Out	8.06M
Stochastic %K	56%
Beta	0.53
Analysts	Strong Sell
Price Target	$9.00